|
KMID : 1011120150090010205
|
|
Bioethics Policy Studies
2015 Volume.9 No. 1 p.205 ~ p.244
|
|
|
Study on the Distinct Characteristics of the IRB’s Roles under the Bioethics and Safety Act in Korea and the Suggestions for the Amendment of the Provisions related to the IRB Operation: Focusing on the IRB of the Medical Institutions Producing Embryos, the Human Material Bank, the Embryo Research Institute, the Somatic-cell Cloning Embryo Research Institute, and the Parthenogenic Embryo Research Institute
|
|
Kim Eun-Ae
|
|
|
Abstract
|
|
|
|
Under the Bioethics and Safety Act, to ensure bioethics and safety, the Institutional Review Board(hereinafter referred to as ‘IRB’) has to be established not only the Human Research Institution and the Human Material Research Institution, but also the Medical Institution Producing Embryos, the Human Material Bank, the Embryo Research Institute, the Somatic-cell cloning embryo research institute, and the Parthenogenic Embryo Research Institute. The functions of the general IRBs such as the IRB of the former research institutions are to review the research whether to decide the approval and to inspect and supervise the progress and outcomes of the IRB approved research. But, in Korea, some IRBs such as the IRB of the latter medical institution and research institutes have the distinct characteristics of its roles, so these IRBs are different from the general IRBs. First, the Medical Institutions Producing Embryos mainly provides the medical treatment for the infertile persons, so it obtains the human gametes to create the human embryos. And, if necessary, it obtains the donated human gametes(especially, women’s oocytes) for the infertile persons. Also it can serve the residual human embryos and gametes to the research institutes. Second, the Human Material Bank secures the donated human materials and related information for the research to supply them to the researchers. Therefore, the IRBs of the Medical Institutions Producing Embryos and the Human Material Bank have to perform the roles related to these works. Third, the researches conducted in the Embryo Research Institute, the Somatic-cell cloning embryo research institute, and the Parthenogenic Embryo Research Institute are very special because the residual human embryos and oocytes containing the ethical issues have to be used. So, the IRBs of these research institutes must have the capacity to review and to inspect and supervise these researches more professionally. But, some provisions of the Bioethics and Safety Act related to these IRB’s distinct characteristics and its roles are a little incomplete and inadequate to support these IRB’s activities as the voluntary self-regulation. Of course, it is a false belief that everything can be solved by the law. However, the law, especially the Bioethics and Safety Act has to be able to present standards to ensure bioethics and safety because both the establishment of these IRBs and the conduct of its roles are based on the law in Korea. So, some provisions related to these IRBs will be able to be amended to support the remarkable activities of these IRBs.
|
|
|
KEYWORD
|
|
|
Institutional Review Board, research, Medical Institutions Producing Embryos, Human Material Bank, Embryo Research Institute, Somatic-cell Cloning Embryo Research Institute, Parthenogenic Embryo Research Institute, Bioethics and Safety Act
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|